Protara Therapeutics Inc. (TARA)
3.44
-0.30 (-8.02%)
At close: Mar 03, 2025, 3:59 PM
3.23
-6.24%
After-hours: Mar 03, 2025, 07:17 PM EST
Protara Therapeutics Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -0.53 | -0.47 | -1.61 | -5.23 | -0.07 | -9.14 | -1.1 | -1.1 | -11.95 | -9.54 | -19.01 | -18.87 |
| PEG Ratio | 0.01 | -0.01 | 0.17 | 0.05 | -0.00 | 0.11 | -1.57 | -0.03 | -0.63 | -0.58 | 37.64 | n/a |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.81 | n/a | n/a |
| PB Ratio | 0.31 | 0.30 | 0.47 | 0.88 | 0.17 | 11.37 | 0.94 | 0.82 | 4.03 | 0.39 | -36.6 | 41.43 |
| P/FCF Ratio | -0.57 | -1.14 | -2.16 | -7.21 | -0.07 | -9.96 | -1.47 | -1.31 | -14.38 | -3.17 | -22.4 | -18.12 |
| P/OCF Ratio | -0.57 | -1.14 | -2.2 | -7.48 | -0.07 | -10.01 | -1.47 | -1.33 | -14.54 | -3.19 | -22.44 | -18.26 |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.39 | n/a | n/a |
| Debt / Equity Ratio | 0.08 | 0.06 | 0.04 | 0.01 | n/a | n/a | 0.00 | n/a | n/a | n/a | -1.23 | n/a |
| Quick Ratio | 11.17 | 14.81 | 21.38 | 58.13 | 11.96 | 7.55 | 4.71 | 8.42 | 16.12 | 36.19 | 0.55 | 6.40 |
| Current Ratio | 11.17 | 15.01 | 21.66 | 58.13 | 11.96 | 7.55 | 4.71 | 8.42 | 16.12 | 36.19 | 0.55 | 6.40 |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.03 | n/a | n/a |
| Interest Coverage | n/a | -58.98 | -27.34 | -1.01K | n/a | n/a | -117.23 | -148.73 | -144.93 | -8.84 | -8.27 | n/a |
| Return on Equity (ROE) | -0.59 | -0.63 | -0.29 | -0.17 | -2.3 | -1.24 | -0.86 | -0.74 | -0.34 | -0.04 | 1.93 | -2.2 |
| Return on Assets (ROA) | -0.51 | -0.57 | -0.27 | -0.16 | -2.11 | -1.08 | -0.68 | -0.66 | -0.32 | -0.04 | -1.4 | -1.02 |
| Return on Capital (ROIC) | -0.6 | -0.62 | -0.28 | -0.17 | -2.39 | -1.28 | -0.87 | -0.75 | -0.33 | -0.09 | 1.73 | -1.22 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100.00% | n/a | n/a |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -113.36% | n/a | n/a |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -113.36% | n/a | n/a |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -257.12% | n/a | n/a |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -340.6% | n/a | n/a |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -83.28% | n/a | n/a |